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Introduction:  
Atherosclerosis is a major cause of harm to human health and leading pathological contributor to 
cardiovascular morbidity and mortality worldwide. Studies during the past decade have highlighted the 
important role of the immune system in atherosclerosis (Libby, 2002; Wick et al., 2004). Consequently, 
reducing the associated inflammation that sustains the immune response has become an important target 
for scientific and future therapeutic investigations because lipid control alone does not effectively 
prevent the progression of atherosclerosis in some patients (Hilgendorf et al., 2014). However, despite a 
long-known association with atherosclerosis, B cells and immunoglobulins, important components of the 
immune system, have received relatively little attention. In particular, the role of B2 cell, which 
represent the vast majority of B cells, include follicular (FO) as well as marginal zone (MZ) B cells also 
have remained largely unexplored (Kyaw et al., 2010; Lipinski et al., 2011; Doran et al., 2012). 
Moreover, at present, there is contradictory evidence concerning the role of B2 cells in atherogenesis 
after adoptive transfer of splenic B2 cells (Kyaw et al., 2010; Lipinski et al., 2011; Doran et al., 2012), 
and dissection of the functions of individual B2-cell subsets (MZ versus FO) and separation of the 
intrinsic biological properties of these B2 cells from effects mediated by the antibodies they secrete 
during atherogenesis have yet to be performed (Tsiantoulas et al., 2014). In addition, the mechanisms by 
which these cells are activated have not been fully elucidated. 
On the other hand, as one important source of antigens, recent studies have suggested that 
commensal microbes could have a substantial impact on atherosclerosis (Koren et al., 2011; Serino et al., 
2014; Tang and Hazen, 2014; Brown and Hazen, 2015). Remarkably, commensal microbes play an 
essential role in the activation of MZ B cells and B2 cell-mediated IgG antibody production (Balázs et 
al., 2002; Martin and Kearney, 2002; Weill et al., 2009; Cerutti et al., 2012; Puga et al., 2012; Vinuesa 
and Chang, 2013). Yet if these effects contribute to the development of atherosclerosis remain largely 
unexplored. In parallel with these findings, our previous clinical research revealed that many 
autoantibodies differing from those found in chronic autoimmune diseases were associated with 
atherosclerosis (Ishigami et al., 2013). Meanwhile, previous studies have reported that human antibodies 
cross-react with outer membrane proteins of bacteria as well as with proteins involved in atherogenesis 
(Canducci et al., 2012). However, the link between B2 cells and commensal microbes in the 
development of atherosclerosis has not yet been reported.  
To address the above issues, we therefore set out to characterize the B2-cell subsets and 
investigated the role of commensal gut flora in triggering B2-cell response during atherogenesis. B2 
cells were shown to play an important immunological role in atherosclerosis and may serve as a target 
for the development of new therapeutic interventions.  
 
Methods and Results:  
Here, we analyzed the contribution of commensal microbes to activate the B2 cell subsets and the 
autoantibody production axis (toll like receptors (TLRs) signaling pathway) during atherogenesis. In 
response to the hyperlipidemic condition, intestinal microbiota in atherosclerosis-prone apolipoprotein E 
knockout (ApoE KO) mice resulted in recruitment and ectopic activation of both FO B cells in 
perivascular adipose tissue (PVAT) and MZ B cells in spleen and, subsequent, an increase in total 
Immunoglobulin (Ig) G and IgG3 levels in the serum, led to the enhanced disease development. In 
contrast, the atherosclerosis is attenuated with disruption of intestinal microbiota by a broad-spectrum 
antibiotic cocktail AVNM as a result of significant and selective reductions of FO B2 cell numbers in 
PVAT and MZ B2 cell in spleen, despite the persistence of serum lipid and lipids metabolism 
abnormalities, such as the increased visceral and subcutaneous fat gain in parallel with the rise in serum 
lipid levels observed at the same time. Moreover, expression analysis of 84 genes related to TLRs 
signaling in the activated B2 cell subsets using the toll like receptors signaling pathway RT2 Profiler 
PCR arrays confirmed activation of the B2 cells autoantibody-production axis, which was associated 
with an increased capacity of B2 cells to bind to intestinal microbiota. Furthermore, the genes encoding 
the inflammation activated-related molecules, including chemokine ligand 2 (Ccl2), heat shock 70kDa 
protein 1a (Hspa1a), interleukin 1 beta (IL1β), interleukin 1 receptor, type 1 (IIl1r1), prostaglandin-
endoperoxide synthase 2 (Ptgs2), tumor necrosis factor receptor superfamily member 1a (Tnfrsf1a) were 
also up-regulated in the activated B2 cell subsets. Meanwhile, the expressions of some TLRs signaling 
related genes, such as CCAAT/enhancer binding protein, beta (Cebpb) and NF-kappa-B inhibitor beta 
(Nfkbib), which are negative regulators of TLRs signaling, were induced after disruption of intestinal 
microbiota by a broad-spectrum antibiotic cocktail AVNM, whereas the expressions of some 
inflammation activated-related genes, such as Hspa1a and Ptgs2 were dramatically reduced. In addition, 
as proof of concept that B2 cells could be targeted therapeutically to reduce atherosclerosis, we 
demonstrated that pharmacological depletion of B2 cells with an anti-B2-cell surface CD23 antibody 
was effective at preventing commensal microbes-derived atherosclerosis in response to hyperlipidemia.  
 
Conclusions:  
Altogether, our results provide evidence for a hitherto unrecognized pathway of immune activation 
in atherosclerosis, which driven by B2 cell that sense microbiota via TLRs pathway and demonstrate that 
the critical role of commensal microbes-specific activation of B2 cell subsets in atherogenesis 
development through lipid metabolism-independent mechanism. Therefore, under hyperlipidemic 
conditions, targeting B2 cell subsets in the treatment represent innovative therapeutic approach. 
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